L Debusscher

1.4k total citations
46 papers, 1.0k citations indexed

About

L Debusscher is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, L Debusscher has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 16 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in L Debusscher's work include Acute Myeloid Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). L Debusscher is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Acute Lymphoblastic Leukemia research (8 papers). L Debusscher collaborates with scholars based in Belgium, Italy and Netherlands. L Debusscher's co-authors include Jean Klášterský, R. Cappel, Stefan Suciu, G. Solbu, M. Peetermans, R Zittoun, C Cauchie, Pierre Stryckmans, U. Jehn and J. Abels and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

L Debusscher

44 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Debusscher Belgium 14 450 286 271 217 201 46 1.0k
E. Kurrle Germany 18 240 0.5× 335 1.2× 166 0.6× 188 0.9× 99 0.5× 68 826
Eliana Zuffa Italy 15 395 0.9× 504 1.8× 150 0.6× 109 0.5× 102 0.5× 43 936
Antonio Spadea Italy 18 539 1.2× 469 1.6× 220 0.8× 101 0.5× 281 1.4× 59 1.2k
G Todeschini Italy 19 391 0.9× 764 2.7× 264 1.0× 153 0.7× 87 0.4× 32 1.6k
Saveria Capria Italy 19 543 1.2× 442 1.5× 278 1.0× 183 0.8× 203 1.0× 70 1.3k
Jack W. Hsu United States 18 518 1.2× 264 0.9× 159 0.6× 138 0.6× 113 0.6× 52 979
Richard Champlin United States 15 870 1.9× 325 1.1× 299 1.1× 197 0.9× 201 1.0× 32 1.5k
B Eklund Finland 22 190 0.4× 128 0.4× 223 0.8× 307 1.4× 162 0.8× 68 1.7k
Mike Potter United Kingdom 24 823 1.8× 409 1.4× 510 1.9× 242 1.1× 157 0.8× 63 1.7k
Erika Borlenghi Italy 19 491 1.1× 462 1.6× 177 0.7× 334 1.5× 119 0.6× 59 1.2k

Countries citing papers authored by L Debusscher

Since Specialization
Citations

This map shows the geographic impact of L Debusscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Debusscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Debusscher more than expected).

Fields of papers citing papers by L Debusscher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Debusscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Debusscher. The network helps show where L Debusscher may publish in the future.

Co-authorship network of co-authors of L Debusscher

This figure shows the co-authorship network connecting the top 25 collaborators of L Debusscher. A scholar is included among the top collaborators of L Debusscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Debusscher. L Debusscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravoet, Christophe, Philippe Mineur, L Debusscher, et al.. (2002). Phase I-II study of a Farnesyl Transferase Inhibitor (FTI), SCH66336, in patients with myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia (sAML).. Blood. 100(11). 7 indexed citations
2.
Bernier, Michel, Caroline Jacquy, Martine Massy, et al.. (1994). Myelomonocytic antigen abnormalities on neutrophils and monocytes in myelodysplastic syndromes. Leukemia Research. 18. 5–5. 1 indexed citations
3.
Razavi, Darius, Nicole Delvaux, Anne Brédart, et al.. (1993). Professional rehabilitation of lymphoma patients: a study of psychosocial factors associated with return to work. Supportive Care in Cancer. 1(5). 276–278. 23 indexed citations
4.
Gratwohl, Aloïs, J. Hermans, Anja van Biezen, et al.. (1993). Splenic Irradiation before Bone Marrow Transplantation for Chronic Myeloid Leukemia: Update of a Prospective Randomized Study. Leukemia & lymphoma. 11(sup1). 227–231. 3 indexed citations
5.
Ljungman, Per, Dan Engelhard, Hartmut Link, et al.. (1992). Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group. Clinical Infectious Diseases. 14(4). 831–835. 139 indexed citations
6.
Antimi, Mauro, M Masi, André Delannoy, et al.. (1991). The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation.. PubMed. 75(5). 443–6. 1 indexed citations
7.
Delforge, A., et al.. (1990). Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors. European Journal Of Haematology. 44(5). 307–311. 10 indexed citations
8.
9.
Velu, Thierry, L Debusscher, & Pierre Stryckmans. (1988). Daunorubicin in patients with relapsed and refractory acute nonlymphoblastic leukemia previously treated with anthracycline. American Journal of Hematology. 27(3). 224–225. 8 indexed citations
10.
Debusscher, L, et al.. (1988). Eosinophilic fasciitis and severe aplastic anemia: favorable response to either antithymocyte globulin or cyclosporine A in blood and skin disorders.. PubMed. 20(3 Suppl 4). 310–3. 8 indexed citations
11.
Stryckmans, Pierre, Théo de Witte, Nizar Bitar, et al.. (1987). Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia.. PubMed. 14(2 Suppl 1). 67–72. 14 indexed citations
12.
Stryckmans, Pierre, L Debusscher, & Eric Collard. (1977). Cell Kinetics in Chronic Granulocytic Leukaemia (CGL). Clinics in Haematology. 6(1). 21–40. 23 indexed citations
13.
Stryckmans, Pierre, et al.. (1977). Factors influencing the release of leukemic blast cells from the marrow into the blood in human acute leukemia. Leukemia Research. 1(2-3). 133–139. 2 indexed citations
14.
Stryckmans, Pierre, et al.. (1976). Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia.. PubMed. 36(9 pt.1). 3034–8. 24 indexed citations
15.
Klášterský, Jean, et al.. (1973). [Diffuse pneumopathy during chemotherapy with busulfan and bleomycin].. PubMed. 55(4). 425–33. 1 indexed citations
16.
Klášterský, Jean, Danièle Weerts, Colette Hensgens, & L Debusscher. (1973). Fever of unexplained origin in patients with cancer. European Journal of Cancer (1965). 9(9). 649–656. 40 indexed citations
17.
Debusscher, L & Jean Klášterský. (1972). Effets Des Variations De L’Inoculum Et Du pH Sur L’Activite De Huit Antibiotiques In Vitro. Acta Clinica Belgica. 27(sup7). 31–40. 1 indexed citations
18.
Klášterský, Jean, et al.. (1972). Bacteriological and Clinical Evaluation of the Combination of Cloxacillin with Ampicillin. Chemotherapy. 17(6). 382–391. 1 indexed citations
19.
Klášterský, Jean & L Debusscher. (1971). Effect of adjustment of the pH upon sensitivity of urinary gram-negative bacilli to nine antibiotics.. PubMed. 4(3). 325–7. 2 indexed citations
20.
Klášterský, Jean, R. Cappel, & L Debusscher. (1971). Effectiveness of Betamethasone in Management of Severe Infections. New England Journal of Medicine. 284(22). 1248–1250. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Kurrle Breakdown of academic impact, for papers by Eliana Zuffa Breakdown of academic impact, for papers by Antonio Spadea Breakdown of academic impact, for papers by G Todeschini Breakdown of academic impact, for papers by Saveria Capria Breakdown of academic impact, for papers by Jack W. Hsu Breakdown of academic impact, for papers by Richard Champlin Breakdown of academic impact, for papers by B Eklund Breakdown of academic impact, for papers by Mike Potter Breakdown of academic impact, for papers by Erika Borlenghi
Rankless by CCL
2026